Potassium Channel

Isoform-selective Products

Cat.No. Product Name Information Product Use Citations Product Validations
S1979 Amiodarone HCl Amiodarone HCl is a sodium/potassium-ATPase inhibitor and an autophagy activator, used to treat various types of cardiac dysrhythmias.
Cancer Cell, 2025, 43(4):776-796.e14
J Immunother Cancer, 2024, 12(11)e009805
Cell Rep Methods, 2023, 3(4):100440
Verified customer review of Amiodarone HCl
S2443 Tolbutamide (HLS 831) Tolbutamide (HLS 831) is an inhibitor of potassium channel, used for type II diabetes.
Adv Healthc Mater, 2024, e2303785.
iScience, 2024, 27(10):110862
UNIVERSITY OF PÉCS, 2023,
S1716 Glyburide (Glibenclamide) Glyburide (Glibenclamide), a known blocker of vascular ATP-sensitive K+ channels (KATP), is used in the treatment of type 2 diabetes.
Cell Chem Biol, 2023, S2451-9456(23)00335-5
BMC Vet Res, 2022, 18(1):145
Front Cell Infect Microbiol, 2021, 11:691445
S1658 Dofetilide Dofetilide (UK-68798) is a selective potassium channel ((hERG)) blocker, used as a Class III antiarrhythmic drug.
Autophagy, 2025, 1-17.
PLoS Pathog, 2020, 16;16(3):e1008341
Toxicol In Vitro, 2020, 104928
S1160 TRAM-34 TRAM-34 (Triarylmethane-34) is a selective and potent inhibitor of the intermediate-conductance Ca2+-activated K+ channel (IKCa1, KCa3.1) with Kd of 20 nM, 200- to 1500-fold selective over other ion channels, and does not block cytochrome P450.
Nat Commun, 2024, 15(1):7566
Pflugers Arch, 2023, 475(3):405-416
Cell Mol Immunol, 2022, 19(8):925-943
S1971 Nicorandil Nicorandil (SG-75) is a potassium channel activator, and stimulates guanylate cyclase to increase formation of cyclic GMP (cGMP).
J Immunother Cancer, 2024, 12(11)e009805
J Cardiovasc Pharmacol Ther, 2022, 27:10742484221088655
BMC Cardiovasc Disord, 2021, 21(1):302
Verified customer review of Nicorandil
S2114 Dronedarone HCl Dronedarone HCl (SR33589) is a multichannel blocker targeting potassium channel, sodium channel and calcium channel, used as an antiarrhythmic drug for treatment of atrial fibrillation (AF).
Cancers (Basel), 2022, 14(19)4883
Chem Res Toxicol, 2021, 10.1021/acs.chemrestox.1c00127
Cell Syst, 2019, 8(2):97-108
Verified customer review of Dronedarone HCl
S2825 ML133 HCl ML133 HCl is a selective potassium channel inhibitor for Kir2.1 with IC50 of 1.8 μM (pH 7.4) and 290 nM (pH 8.5), has no effect on Kir1.1 and weak activity for Kir4.1 and Kir7.1.
Cell Mol Immunol, 2022, 19(8):925-943
Nat Commun, 2022, 13(1):3544
Mol Pain, 2019, 15:1744806919838947
S2562 Hydralazine HCl Hydralazine HCl is a hydrochloride salt of hydralazine, which is a direct-acting smooth muscle relaxant used to treat hypertension by acting as a vasodilator primarily in arteries and arterioles.
J Immunother Cancer, 2024, 12(11)e009805
Acta Pharm Sin B, 2023, 13(1):142-156
Acta Pharm Sin B, 2023, 13(1):142-156
S4734 Retigabine 2HCl Retigabine 2HCl (D-23129) is a novel anticonvulsant with activity in a broad range of seizure models. The mechanism of action involves opening of neuronal K(V)7.2-7.5 (formerly KCNQ2-5) voltage-activated K(+) channels.
J Biol Chem, 2021, S0021-9258(21)00985-6
Front Physiol, 2021, 12:790580
SSRN, 2021, 25 Pages

Signaling Pathway Map